ARCHIVES

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

On Biomedical Malthusianism; Varmus, et al. Propose a Strategy For Saving Biomedical Research

May 2, 2014

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977

In Brief: New Biomedical Research Panel To Organize Feb. 24-25, Discuss Mandate, Priorities

February 14, 1975

Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants

April 2, 1999

The Walgreens Connection: ACS Calls On Drug Stores To Stop Tobacco Sales

April 18, 2014

NCI Advisory Group, other Cancer Meetings

July 29, 1988